View DividendBeit Jala Pharmaceutical マネジメントマネジメント 基準チェック /04現在、CEO に関する十分な情報がありません。主要情報 最高経営責任者n/a報酬総額CEO給与比率n/aCEO在任期間no dataCEOの所有権n/a経営陣の平均在職期間データなし取締役会の平均在任期間データなし経営陣の近況No independent directors Oct 03No independent directors Aug 29No independent directors Oct 17No independent directors Sep 13No independent directors Jul 17No independent directors May 24すべての更新を表示Recent updatesNo independent directors Oct 03Second quarter 2024 earnings released: EPS: د.أ0.047 (vs د.أ0.11 in 2Q 2023) Sep 03No independent directors Aug 29No independent directors Oct 17No independent directors Sep 13No independent directors Jul 17No independent directors May 24No independent directors Apr 11No independent directors Mar 24No independent directors Dec 17No independent directors Nov 28No independent directors Oct 19No independent directors Sep 05No independent directors Aug 15No independent directors Jun 16No independent directors May 05No independent directors Apr 04No independent directors Mar 03No independent directors Nov 10No independent directors Sep 27No independent directors Sep 01CEO（最高経営責任者Beit Jala Pharmaceutical CEOがいない、あるいは彼らに関するデータがない。View Ownership